Atlas Trials

A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies

Clinical trial NCT01798745 · WITHDRAWN

Trial details

NCT number
NCT01798745
Sponsor
Janssen Research & Development, LLC
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Heart Failure
Start date
2014-11-01
Primary completion
2015-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.